Additionally, IMiDs have been found not only to have immunomodulative effects on T cells (hence the name), but also to have antiproliferative effects on multiple myeloma cell types by recruiting the transcription factors Ikaros (IKZF1) and Aiolos (IKZF3) for its degradation [66]. The gene discussed is IKZF3; the disease is plasma cell myeloma.